CDLX vs PFE · rev $278.3M vs P/E 20, rev $62.58B
Cardlytics Inc (CDLX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Cardlytics Inc (CDLX) is a advertising agencies company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CDLX revenue for 2024-12-31 was $278.3M. Net income was -$189.3M. Revenue was down 10.0% from 2023-12-31 to 2024-12-31. CDLX currently screens at market cap $95.0M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CDLX currently screens at market cap $95.0M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CDLX and PFE stock pages for the full models.
Not investment advice.